Vaxcyte, Inc. ($PCVX)
Filing Information
| Accession Number | 0001813798-26-000017 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 2, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
10,682
Total Value
$389,893.71
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF OPERATING OFFICER | Common Stock | โ | Aug 31, 2026 | Tax Withholding | 1,273 | $60.74 | $77,322.02 | 156,268 | Direct | โ | View Details | |
CHIEF OPERATING OFFICER | Common Stock | โ | Sep 1, 2026 | Exercise/Conversion | 2,250 | $5.35 | $12,037.50 | 158,518 | Direct | โ | View Details | |
CHIEF OPERATING OFFICER | Common Stock | โ | Sep 1, 2026 | Sale | 1,537 | $60.89 | $93,581.78 | 156,981 | Direct | โ | View Details | |
CHIEF OPERATING OFFICER | Common Stock | โ | Sep 1, 2026 | Sale | 713 | $61.48 | $43,835.95 | 156,268 | Direct | โ | View Details | |
CHIEF OPERATING OFFICER | Common Stock | โ | Sep 1, 2026 | Sale | 924 | $60.95 | $56,322.42 | 155,344 | Direct | โ | View Details | |
CHIEF OPERATING OFFICER | Common Stock | โ | Sep 1, 2026 | Sale | 303 | $61.42 | $18,611.47 | 155,041 | Direct | โ | View Details | |
CHIEF OPERATING OFFICER | Common Stock | โ | Sep 2, 2026 | Tax Withholding | 1,432 | $61.58 | $88,182.56 | 153,609 | Direct | โ | View Details | |
CHIEF OPERATING OFFICER | Stock Option (right to buy) | Derivative | Sep 1, 2026 | Exercise/Conversion | 2,250 | $0.00 | $0.00 | 66,648 | Direct | โ | View Details |